Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04092777 · ClinicalTrials.gov registry record · NA

Building Infrastructure for Community Capacity in Accelerating Integrated Care

A NA study of Mental Health, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
1,044
Enrollment target
2
Study locations

NCT04092777: Completed NA study of Mental Health, sponsored by Massachusetts General Hospital.

NCT04092777 is a NA study of Mental Health that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,044 participants, below the 10,166-participant average among 62 other Mental Health trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04092777, a NA study of Mental Health, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
1,044 participants
Enrollment target
2
Study locations

Study Summary

Although the Affordable Care Act (ACA) expanded Medicaid eligibility, Medicaid expansions do not appear to have decreased the gap in mental health treatment between Whites and racial/ethnic or linguistic minorities. There is a critical shortage of trained providers who can offer culturally congruent mental health service in non-English languages in Medicaid-based Accountable Care Organizations (ACOs). Building capacity and training opportunities to implement evidence-based mental health interventions by community health workers (CHWs) could expand ACOs infrastructure and increase access to and quality of mental healthcare. To this end, the investigators will test the effectiveness and implementation of the STRONG MINDS model to improve engagement and quality of treatment for depression and anxiety among low-income racial/ethnic and linguistic minority populations, served by Medicaid ACOs. Our proposed study is a Hybrid Type I Effectiveness Implementation study of the effectiveness of the mental health intervention and its impact on study outcomes within varying contexts associated with Medicaid ACOs in North Carolina (NC) and Massachusetts (MA).

Primary Outcome

Engagement in Mental Health Intervention Sessions was measured as attending 2 or more (out of 10) sessions of STRONG MINDS. This outcome was measured among intervention participants only (Strong Minds Program) using an indicator variable equal to one if a participant attended 2+ intervention sessions, and equal to zero otherwise.

Conditions Studied

Interventions

  • OTHER Enhanced Usual Care
  • BEHAVIORAL Strong Minds

Study Locations (2)

Massachusetts

  • South Cove Community Health Center - Quincy
  • MGH Broadway Primary Care - Revere - Revere

Trial Details

FieldValue
Enrollment Target 1,044 participants
Start Date 2019-08-30
Est. Completion 2023-11-16
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT04092777 record still lists

NCT04092777 is an interventional study that assigns participants to a tested intervention. Its 1,044 participants enrollment target places it among the larger protocols in the corpus, below the 10,166-participant average among 62 other Mental Health trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Mental Health appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT04092777 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04092777 about?

NCT04092777 is a clinical study titled "Building Infrastructure for Community Capacity in Accelerating Integrated Care". Although the Affordable Care Act (ACA) expanded Medicaid eligibility, Medicaid expansions do not appear to have decreased the gap in mental health treatment between Whites and racial/ethnic or linguistic minorities. There is a critical shortage of trained providers who can offer culturally congruent...

What is the current status of trial NCT04092777?

This trial is currently completed. It is a NA study. The enrollment target is 1,044 participants. The study started on 2019-08-30. Estimated completion is 2023-11-16.

What conditions does trial NCT04092777 study?

This clinical trial studies the following conditions: Mental Health.

What interventions are being tested in trial NCT04092777?

The interventions under investigation include: Enhanced Usual Care (OTHER), Strong Minds (BEHAVIORAL).

Who is sponsoring clinical trial NCT04092777?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04092777 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04092777's enrollment target sits among peer trials

1,044 11th of 62 higher than 52 of 62 other Mental Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06717347 · 1,046 participants · Phase 3

    A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  • NCT04685616 · 1,042 participants · Phase 3

    Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

  • NCT05219110 · 1,040 participants · NA

    Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

  • NCT06564948 · 1,040 participants · NA

    Treatment for Individuals Interacting with the Criminal Justice System

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04092777, the US trial registry maintained by the National Library of Medicine. NCT04092777 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.